Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1465555 | 0.83 | CCNB2 (0.30) | XDHALDH1A1 | |
| SCHEMBL11213548 | 0.73 | PDE3B (0.31) | — | |
| SCHEMBL11788495 | 0.73 | FFAR1 (0.31) | — | |
| SCHEMBL10417506 | 0.73 | MAPKAPK2 (0.33) | — | |
| SCHEMBL28323729 | 0.73 | PDXK (0.32) | NPSR1 | |
| SCHEMBL1525816 | 0.72 | ALDH1A1 (0.59) | XDHGABRA1GABRB2ALDH1A1KDM4E | |
| Hydrochloric Acid SCHEMBL6676790 | 0.71 | ALDH1A1 (0.57) | XDHGABRA1GABRB2ALDH1A1KDM4E | |
| SCHEMBL10716783 | 0.71 | KDM4E (0.37) | ALDH1A1KDM4EMEN1GAAMAPT | |
| SCHEMBL28988139 | 0.71 | ADORA3 (0.34) | KDM4EMEN1HPGDKMT2A | |
| SCHEMBL11327091 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100371330-C | Method for separating and purifying polyhydroxy alkyl pyrazine compound from sugar ammonia reaction liquid | CHINA TOBACCO HUNAN IND CORP (CN) | 2008-02-27 | — | — | CN | claimed |
| CN-1289487-C | Method for separation purification of polyhydroxy-alkyl-pyrazine from suger amine reaction liquid | CHANGSHA CIGARETTE FACTORY (CN) | 2006-12-13 | — | — | CN | claimed |
| CN-1803779-A | Method for purifying polyhydroxy alkyl pyrazine compound from browning reaction liquor | CHANGSHA CIGARETTE FACTORY (CN) | 2006-07-19 | — | — | CN | claimed |
| CN-1603313-A | Method for separation purification of polyhydroxy-alkyl-pyrazine from suger amine reaction liquid | CHANGSHA CIGARETTE FACTORY (CN) | 2005-04-06 | — | — | CN | claimed |
| JP-5246805-A | — | — | None | — | — | JP | disclosed |
| CN-118184589-A | Preparation process of deoxyfructosazine and application of deoxyfructosazine and fructosazine in cosmetics | 大连理工大学 | 2024-06-14 | — | — | CN | disclosed |
| US-8198461-B2 | Process for the preparation of 3-cyano-1,2,4-triazoles | AMPAC FINE CHEMICALS LLC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-20090292122-A1 | PROCESS FOR THE PREPARATION OF CYANO-SUBSTITUTED-NITROGEN-CONTAINING HETEROARYL COMPOUNDS | AMPAC FINE CHEMICALS LLC (US) | 2009-11-26 | — | — | US | disclosed |
| WO-2009137742-A1 | PROCESS FOR THE PREPARATION OF CYANO-SUBSTITUTED-NITROGEN-CONTAINING HETEROARYL COMPOUNDS | AMPAC FINE CHEMICALS LLC (US) | 2009-11-12 | — | — | WO | disclosed |
| CN-100371330-C | Method for separating and purifying polyhydroxy alkyl pyrazine compound from sugar ammonia reaction liquid | CHINA TOBACCO HUNAN IND CORP (CN) | 2008-02-27 | — | — | CN | disclosed |
| CN-1289487-C | Method for separation purification of polyhydroxy-alkyl-pyrazine from suger amine reaction liquid | CHANGSHA CIGARETTE FACTORY (CN) | 2006-12-13 | — | — | CN | disclosed |
| CN-1289487-C | Method for separation purification of polyhydroxy-alkyl-pyrazine from suger amine reaction liquid | CHANGSHA CIGARETTE FACTORY (CN) | 2006-12-13 | — | — | CN | disclosed |
| US-4137234-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-01-30 | — | — | US | disclosed |
| US-4137237-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-01-30 | — | — | US | disclosed |
| US-4070475-A | THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1978-01-24 | — | — | US | disclosed |
| US-4024271-A | INHIBITORS OF HISTAMINE ACTIVITY | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-17 | — | — | US | disclosed |
| US-4022797-A | PHARMACEUTICALS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-10 | — | — | US | disclosed |
| US-4018931-A | INHIBITION OF H-2 HISTAMINE RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-04-19 | — | — | US | disclosed |
| US-3950353-A | HISTAMINE INHIBITORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |
| US-3950333-A | HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292122-A1 | PROCESS FOR THE PREPARATION OF CYANO-SUBSTITUTED-NITROGEN-CONTAINING HETEROARYL COMPOUNDS | ASNS, NCL, NBAS | XDH 1916/4885GABRA1 1400/4885GABRB2 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.